Laprophan Group Acquires Controlling Stake in Rivopharm
June 17, 2026
Laprophan Group completed the acquisition of a controlling stake in Rivopharm, a Switzerland-based specialty pharmaceutical company focused on specialty medicines, dossier development, and complex formulations. The deal strengthens Laprophan’s European footprint and supports its ambition to build an international pharmaceutical platform across Europe, Africa, the Middle East, and selected global markets.
- Buyers
- Laprophan Group, Europhan
- Targets
- Rivopharm
- Platforms
- Europhan
- Industry
- Pharmaceuticals
- Location
- Ticino, Switzerland
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.